Viking Therapeutics' stock soars 61% premarket after company

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Related Keywords

, Drug Administration , Therapeutics Inc , Viking Therapeutics , Article Normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural Machinery , Health Care , Biopharmaceuticals , Specialized Drugs Medications , Hormone Products , Industrial Goods , Diabetes Drugs , Regulation Government Policy , Financial Performance , Share Price Movement Disruptions , New Products Services , Research Development , Corporate Industrial News , Products Services , New Product Service Testing , Political General News , Society Community , Diabetes , Physical Mental Fitness , Health , Living Lifestyle , Medical Conditions , Obesity , Social Issues , Weight Management , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Viking Therapeutics Inc , Vktx , Novo Nordiskas Adr , Nvo , Novo Nordiska S , Dk Novo B , Eli Lilly Amp Co , Rally , Spx , S Amp Ampp 500 Index , Regulation , Government Policy , Share Price Movement , Disruptions , New Products , Services , Research , Development , Corporate , Industrial News , Products , New Product , Service Testing , Political , General News , Society , Community , Physical , Mental Fitness , Living , Lifestyle , Specialized Drugs , Medications ,